nomilin has been researched along with Obesity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashidume, T; Inoue, J; Ono, E; Sato, R; Shimizu, M | 1 |
| Sato, R | 1 |
1 review(s) available for nomilin and Obesity
| Article | Year |
|---|---|
Nomilin as an anti-obesity and anti-hyperglycemic agent.
Topics: Animals; Anti-Obesity Agents; Benzoxepins; Diabetes Mellitus; Humans; Hypoglycemic Agents; Limonins; Obesity | 2013 |
1 other study(ies) available for nomilin and Obesity
| Article | Year |
|---|---|
Anti-obesity and anti-hyperglycemic effects of the dietary citrus limonoid nomilin in mice fed a high-fat diet.
Topics: Animals; Anti-Obesity Agents; Benzoxepins; Blood Glucose; Citrus; Diet; Dietary Fats; Gene Expression; HEK293 Cells; Humans; Hyperglycemia; Hypolipidemic Agents; Insulin; Iodide Peroxidase; Iodothyronine Deiodinase Type II; Ligands; Limonins; Male; Mice; Obesity; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Receptors, G-Protein-Coupled; Trans-Activators; Transcription Factors | 2011 |